Accéder au contenu
MilliporeSigma

Principaux documents

Voir toute la documentation

746452

Sulfate de magnésium

anhydrous, free-flowing, Redi-Dri™, ReagentPlus®, ≥99.5%

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Changer de vue

A propos de cet article

Formule empirique (notation de Hill) :
MgSO4
Numéro CAS:
7487-88-9
Poids moléculaire :
120.37
NACRES:
NA.21
PubChem Substance ID:
329765769
UNSPSC Code:
12352302
EC Number:
231-298-2
MDL number:
MFCD00011110
Assay:
≥99.5%
Grade:
anhydrous
Form:
powder
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

grade

anhydrous

Quality Level

100

agency

suitable for SM 5210

vapor density

<0.01 (vs air)

vapor pressure

<0.1 mmHg ( 20 °C)

product line

ReagentPlus®, Redi-Dri™

assay

≥99.5%

form

powder

quality

free-flowing

pH

~7.9 (25 °C, 50 g/L)

SMILES string

[Mg++].[O-]S([O-])(=O)=O

InChI

1S/Mg.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2

InChI key

CSNNHWWHGAXBCP-UHFFFAOYSA-L

General description

Magnesium sulfate is a magnesium salt with tocolytic ability. Its role to induce an analgesic effect during intraoperative and postoperative periods has been investigated. It is reported to prevent eclampsia. Its ability to remove water from water-miscible solvents by salting-out phase separation has been studied.

Application

Magnesium sulfate may be used as a drying agent for organic extracts.

Features and Benefits

  • Increased efficiency – Eliminate time and effort of loosening hardened powders
  • Safety – Avoid risks of using tools of force to break up clumps
  • Economy – Faster preparation and solvation increase productivity and reduce costs
  • Assured quality – Excellent, expert-tested quality with no anti-caking agents
  • Flexible volumes – Available from research amounts to scale-up quantities

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

Still not finding the right product?

Explore all of our products under Sulfate de magnésium

Classe de stockage

13 - Non Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Articles

Redi-Dri™ – The World of Free-flowing Hygroscopic Products

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Contenu apparenté

Environmental Methods Consumables Look Up Tool

This page is intended to make it easier to find the consumables you need based on the analytical method you’re using. Methods included on this page come from the EPA, Standard Methods and ASTM.

Lex W Doyle et al.
Obstetrics and gynecology, 113(6), 1327-1333 (2009-05-23)
To systematically review rates of neurologic outcomes reported in childhood for the preterm fetus exposed to antenatal magnesium sulfate. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register, CENTRAL (The Cochrane Library 2008, Issue 3), relevant references from retrieved
Lex W Doyle
Current opinion in pediatrics, 24(2), 154-159 (2012-01-10)
Antenatal magnesium sulfate may reduce the excessive rates of cerebral palsy in survivors of very preterm birth. There are five randomized controlled trials of magnesium sulfate therapy given to the mother prior to very preterm birth which have reported neurological
Federica Belluti et al.
ChemMedChem, 9(2), 371-382 (2014-01-10)
A significant improvement in the treatment of trypanosomiases has been achieved with the recent development of nifurtimox-eflornithine combination therapy (NECT). As an alternative to drug combinations and as a means to overcome most of the antitrypanosomatid drug discovery challenges, a
Afficher tous les articles scientifiques apparentés

Numéro d'article de commerce international

RéférenceGTIN
746452-2.5KG04061832891231
746452-6X500G04061832891262
746452-100G04061832581071
746452-12KG04061838351876
746452-1KG04061832891217
746452-4X2.5KG04061832891248
746452-500G04061832891255
746452-6X1KG04061832581088